0
Abstract: Slide Presentations |

Changes in Platelet Surface-Marker Expression During Heart Surgery - Comparison of two Different Heart-Lung-Machine Systems FREE TO VIEW

Thomas Waldow, MD*; Oliver Tiebel, MD; Utz Kappert, MD; Volker Schmidt; Gunther Schumann; Peter Lattke, MD; Peter Gladun, MD; Klaus Matschke, MD; Gabriele Siegert, MD
Author and Funding Information

Technical University of Dresden, Dresden, Germany


Chest


Chest. 2004;126(4_MeetingAbstracts):734S. doi:10.1378/chest.126.4_MeetingAbstracts.734S
Text Size: A A A
Published online

Abstract

PURPOSE:  Platelets contain and release a variety of receptor molecules and molecules which influence platelet adhesion and aggregation. They are also a source of coagulation factors as well as regulators of coagulation and fibrinolysis. Via different surface molecules they interact with each other as well as different ligands from the vessel wall and the blood plasma. In the present study, the expression of platelet surface proteins was determined in order to compare the effects of two different heart-lung-machines (HLM) on platelet activation.

METHODS:  The study was performed as prospective, randomized, single-blinded study. Fourty patients were recruited into two groups according to the application of different HLM systems. A standard system (group 1) is compared with a modified HLM which is designed to minimize procoagulatory effects by using a Deltastream pump, surface-modified tubing, and a reduced priming volume (group 2). Blood was collected at different time points before, during, and after surgical intervention (CABG). Platelets were incubated with either CD42b-FITC-/ CD62P-PE- or Factor Va-FITC-/ Tissue Factor-PE-labeled antibodies. Analysis was performed using a FACSCalibur flowcytometric system.

RESULTS:  There was no significant change in the CD62P expression during CABG, and no difference among groups. The expression of CD42b decreased significantly at the end of the observation period in group 1 but not in group 2. Factor Va expression was significantly elevated in group 1 between the beginning and 10 min after the end of the surgical intervention, but without differences between groups. Tissue factor expression did not disclose any significant change or difference between groups. In contrast, the expression of Glycoprotein Ib-alpha, a subunit of the von Willebrandt-Receptor-Complex, decreased in group 2 at the end of CABG.

CONCLUSION:  The results exclude a global platelet activation for both HLM systems, but the differences in the expression of Factor Va, CD42b, and Glycoprotein Ib-alpha indicate effects of the HLM modification.

CLINICAL IMPLICATIONS:  Modifications in extracorporeal circulation setups that are in routine use in cardiac surgery influence platelet activation.

DISCLOSURE:  T. Waldow, None.

Tuesday, October 26, 2004

10:30 AM- 12:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543